Author

F. Murianni

1 paper indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

CELLULAR AND GENE THERAPIES

Anti-CD38-CAR-allogeneic gd T-cell therapy is expected to be a highly effective and feasible treatment for patients with relapsed and refractory myeloma as an off-the-shelf use.

Y. Hattori, N. Ohshima, Y.Taniguchi et al. · 2 citations